How is it wrong? We all saw the slide Alter presented at the conference.
I've just realised what's been bugging me.
Was it really water-tight that the WPI results which had been validated were the ones linking XMRV to CFS?
Seeing as this was related to blood safety, could they have just been refering to XMRV being present in blood, and potentially transmissable via transfusion? Or the result that 4% of the population have an XMRV infection?
From this "Although blood transmission to humans has not been proved, it is probable. The association with CFS is very strong, but causality not proved. XMRV and related MLVs are in the donor supply with an early prevalence estimate of 3%‐7%. We (FDA & NIH) have independently confirmed the Lombardi group findings" it's possible that they did not even look at CFS patients.
From the look of the slides, I'd say he was talking about CFS - but we can't hear what he was saying while these slides were up - and the slide isn't as clear as I'd like. Hopefully I'm being over cautious here, but it's possible we've really mis-read this.